| 股票 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▾ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 药明康德 603259 | 医疗服务 | 21.3 | 20.8 | 0.95 | 5.55 | 1.4% | 60% | 41% | 24% | 0.6 | 2.8% | +5% | +73% | +74% | +58% | -23% | 45% | 4622 |
| 贝达药业 300558 | 化学制药 | 44.3 | 36.1 | 1.09 | 3.13 | 0.3% | 20% | 84% | 28% | 2.0 | 1.3% | +15% | -13% | +5% | -33% | -46% | 56% | 207 |
| 兴齐眼药 300573 | 化学制药 | 16.9 | 11.4 | 0.36 | 6.17 | 3.1% | 77% | 78% | 51% | 0.1 | 4.5% | +26% | +46% | -21% | -17% | -38% | 40% | 133 |
| 可孚医疗 301087 | 医疗器械 | 30.1 | 25.0 | 1.04 | 2.21 | 3.4% | 98% | 44% | 22% | 1.3 | 3.6% | +4% | +34% | +19% | +34% | -28% | 42% | 122 |
| 迪安诊断 300244 | 医疗服务 | 41.8 | 24.5 | 1.07 | 1.71 | 1.9% | 249% | 31% | 8% | 1.6 | 15.8% | -21% | +44% | +15% | +9% | -46% | 64% | 111 |
| 三诺生物 300298 | 医疗器械 | 66.9 | 22.7 | 0.99 | 3.01 | — | 38% | 55% | 30% | 2.0 | 4.8% | +18% | -33% | -6% | -25% | -36% | 25% | 89 |
| 汇宇制药 688553 | 化学制药 | 66.1 | 1198.0 | 1.06 | 2.01 | 1.1% | 95% | 86% | 28% | 3.5 | 1.8% | -13% | +21% | +1% | -35% | -46% | 56% | 75 |
| 九强生物 300406 | 医疗器械 | 30.7 | 16.9 | 0.77 | 2.01 | 8.9% | 44% | 75% | 10% | 2.0 | 7.8% | -4% | +5% | -4% | -14% | -26% | 29% | 69 |
| 千金药业 600479 | 中药Ⅱ | 19.1 | 17.1 | 1.07 | 2.14 | 2.9% | 57% | 46% | 11% | 0.3 | 7.1% | -3% | -2% | +34% | +20% | -18% | 33% | 65 |
| 毕得医药 688073 | 医疗服务 | 29.3 | 24.3 | 1.06 | 2.58 | 1.9% | 68% | 44% | 4% | 0.4 | 1.5% | +17% | +27% | -2% | -11% | -44% | 67% | 53 |
| 圣诺生物 688117 | 化学制药 | 25.5 | 20.0 | 0.71 | 4.54 | 1.1% | 32% | 64% | 38% | 1.8 | 0.9% | +23% | +110% | -12% | -24% | -34% | 47% | 52 |
| 山外山 688410 | 医疗器械 | 24.2 | 16.6 | 0.50 | 2.47 | 1.4% | 45% | 45% | 20% | 0.0 | 0.5% | +28% | +36% | -5% | -13% | -27% | 42% | 45 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。